Search results for "Peptic Ulcer Hemorrhage"

showing 4 items of 4 documents

Helicobacter pylori infection does not affect the early rebleeding rate in patients with peptic ulcer bleeding after successful endoscopic hemostasis…

2003

Background and study aims Eradication of Helicobacter pylori infection can reduce the rebleeding rate of peptic ulcer bleeding in the long term. There are few data on the influence of H. pylori on the rebleeding rate in the acute phase of bleeding however. We therefore prospectively investigated the influence of H. pylori infection on the early rebleeding rate in patients who had undergone successful endoscopic hemostasis treatment for peptic ulcer bleeding. Patients and methods Between January 1996 and November 2000 all patients with peptic ulcer bleeding were evaluated consecutively. The diagnosis of H. pylori infection was made at index endoscopy, using histology and the rapid urease tes…

AdultMalemedicine.medical_specialtyPeptic UlcerAdolescentRapid urease testPeptic Ulcer HemorrhageGastroenterologyStatistics NonparametricHelicobacter InfectionsRecurrenceInternal medicineGastroscopymedicineHumansProspective StudiesProspective cohort studyAgedProbabilityAged 80 and overbiologyHelicobacter pyloribusiness.industryHemostasis EndoscopicGastroenterologyHelicobacter pyloriMiddle Agedbiology.organism_classificationSurgeryLogistic ModelsPeptic Ulcer HemorrhageTreatment OutcomeForrest classificationHemostasisFemaleGastritismedicine.symptomComplicationbusinessFollow-Up StudiesEndoscopy
researchProduct

The prognosis of patients having received optimal therapy for nonvariceal upper gastrointestinal bleeding might be worse in daily practice than in ra…

2010

International audience; BACKGROUND: Combination of endoscopic haemostatic and high-dose intravenous proton-pump inhibitors is considered to be the standard care for patients with acute peptic ulcer bleeding. AIM: This study assessed predictive factors of rebleeding and death in unselected patients presented to our hospital. METHODS: Consecutive patients with nonmalignant bleeding ulcers and stigmata of recent haemorrhage who received optimal treatment, between 22 August 2003 and 15 October 2007, were studied retrospectively. RESULTS: Among 140 included patients, 45 (32%) rebled and 30 received another haemostatic endoscopy, which was successful in 20 cases. In multivariate analysis, the onl…

MaleMultivariate analysisAdministration Oral2-Pyridinylmethylsulfinylbenzimidazoleslaw.inventionHospitals University0302 clinical medicineRandomized controlled trialRecurrenceRisk FactorslawOdds RatioHospital Mortality030212 general & internal medicineInfusions IntravenousPantoprazoleRandomized Controlled Trials as TopicAged 80 and overMortality rateHemostasis EndoscopicGastroenterologyMiddle AgedCombined Modality TherapyIntensive care unit3. Good healthIntensive Care UnitsPeptic Ulcer HemorrhageTreatment OutcomeInjections IntravenousFemale030211 gastroenterology & hepatologyFranceAdultmedicine.medical_specialtyRisk AssessmentYoung Adult03 medical and health sciencesInternal medicinemedicineHumansAgedRetrospective StudiesChi-Square DistributionHepatologybusiness.industryProton Pump Inhibitors[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and GastroenterologyOdds ratiomedicine.disease[SDV.MHEP.HEG] Life Sciences [q-bio]/Human health and pathology/Hépatology and GastroenterologyConfidence intervalSurgeryLogistic ModelsUpper gastrointestinal bleedingRockall scorebusiness
researchProduct

Endoscopic hemostasis followed by preventive transarterial embolization in high-risk patients with bleeding peptic ulcer: 5-year experience

2019

Abstract Background Upper gastrointestinal bleeding (UGIB) due to peptic ulcer disease is one of the leading causes of death in patients with non-variceal bleeding, resulting in up to 10% mortality rate, and the patient group at high risk of rebleeding (Forrest IA, IB, and IIA) often requires additional therapy after endoscopic hemostasis. Preventive transarterial embolization (P-TAE) after endoscopic hemostasis was introduced in our institution in 2014. The aim of the study is an assessment of the intermediate results of P-TAE following primary endoscopic hemostasis in patients with serious comorbid conditions and high risk of rebleeding. Methods During the period from 2014 to 2018, a tota…

Malemedicine.medical_specialtyLeft gastric arteryTransarterial embolizationmedicine.medical_treatmentlcsh:SurgeryNon-variceal gastrointestinal bleeding030230 surgeryGastroduodenal artery03 medical and health sciences0302 clinical medicineRecurrencePreventivemedicine.arterymedicineHumansEmbolizationAgedAged 80 and overbusiness.industryMortality rateHemostasis Endoscopiclcsh:Medical emergencies. Critical care. Intensive care. First aidlcsh:RD1-811lcsh:RC86-88.9Middle Agedmedicine.diseaseEmbolization TherapeuticSurgeryPeptic Ulcer HemorrhageTreatment OutcomeEmergency MedicineFemale030211 gastroenterology & hepatologySurgeryFresh frozen plasmaUpper gastrointestinal bleedingPacked red blood cellsRockall scorebusinessResearch ArticleWorld Journal of Emergency Surgery
researchProduct

Is routine second-look endoscopy effective after endoscopic hemostasis in acute peptic ulcer bleeding? A meta-analysis

2012

Background Routine second-look endoscopy in modern-era peptic ulcer bleeding (PUB) remains controversial. Objective To assess the effectiveness of routine second-look endoscopy in patients with PUB exhibiting high-risk stigmata after standard medical care and endoscopic therapy. Design Comprehensive literature searches (1990-2011) were performed, seeking randomized trials comparing a routine with an as-needed second endoscopy. Main Outcome Measurements The main outcome was rebleeding. Secondary outcomes were surgery and mortality. Subanalyses assessed the influence of study quality, rebleeding definitions, endoscopic hemostasis modality, and proton pump inhibitor (PPI) therapies. Analyses w…

Riskmedicine.medical_specialtymedicine.drug_classMEDLINEProton-pump inhibitorlaw.inventionRandomized controlled trialRecurrencelawOdds RatiomedicineHumansRadiology Nuclear Medicine and imagingModels Statisticalmedicine.diagnostic_testbusiness.industryHemostasis EndoscopicGastroenterologyProton Pump InhibitorsOdds ratioConfidence intervalSurgeryEndoscopyPeptic Ulcer HemorrhageTreatment OutcomeMeta-analysisHemostasisbusinessGastrointestinal Endoscopy
researchProduct